Novel cancer vaccine based on genes of Salmonella pathogenicity island 2

International Journal of Cancer

Volumn 126, Issue 11, 2010, Pages 2622-2634

  Xiong, Guosheng ^a   Husseiny, Mohamed I ^a,b   Song, Liping ^c   Erdreich Epstein, Anat ^a   Shackleford, Gregory M ^a   Seeger, Robert C ^a   Jäckel, Daniela ^d   Hensel, Michael ^e   Metelitsa, Leonid S ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Zagazig University   (Egypt)

^c CENTER FOR CELL AND GENE THERAPY   (United States)

^d Mikrobiologisces Institut Infektionsbiologische Abteilung   (Germany)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cancer vaccine; Cells; Natural killer T (NKT); Salmonella; Salmonella pathogenicity island 2 (SPI2); Survivin

Indexed keywords

ALPHA GLUCURONOSYLCERAMIDE; CANCER VACCINE; CD1D ANTIGEN; CERAMIDE; INTERLEUKIN 12; SURVIVIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; MICROTUBULE ASSOCIATED PROTEIN; SURVIVIN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CANCER INHIBITION; CD8+ T LYMPHOCYTE; COLON CARCINOMA; CONTROLLED STUDY; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOGENICITY; MACROPHAGE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PATHOGENICITY ISLAND; PATHOGENICITY ISLAND 2; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; ANIMAL; BAGG ALBINO MOUSE; BRAIN TUMOR; COLON TUMOR; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; NATURAL KILLER CELL; PATHOGENICITY; PATHOLOGY; SALMONELLA; SALMONELLOSIS; T LYMPHOCYTE; TUMOR CELL LINE; VACCINATION; VIRULENCE;

ANIMALS; BRAIN NEOPLASMS; CANCER VACCINES; CELL LINE, TUMOR; COLONIC NEOPLASMS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICROTUBULE-ASSOCIATED PROTEINS; SALMONELLA; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES; VACCINATION; VIRULENCE;

EID: 77951218320     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24957     Document Type: Article

References (66)

1. Gilboa E. DC-based cancer vaccines. J Clin Invest 2007;117:1195-1203
2. Schoen C, Stritzker J, Goebel W, Pilgrim S. Bacteria as DNA vaccine carriers for genetic immunization. Int J Med Microbiol 2004;294:319-335
3. Vassaux G, Nitcheu J, Jezzard S, Lemoine NR. Bacterial gene therapy strategies. J Pathol 2006;208:290-298
4. Gentschev I, Dietrich G, Spreng S, Kolb-Maurer A, Brinkmann V, Grode L, Hess J, Kaufmann SH, Goebel W. Recombinant attenuated bacteria for the delivery of subunit vaccines. Vaccine 2001;19:2621-2628 (Pubitemid 32234281)
5. Verjans GM, Janssen R, UytdeHaag FG, van Doornik CE, Tommassen J. Intracellular processing and presentation of T cell epitopes, expressed by recombinant Escherichia coli and Salmonella typhimurium, to human T cells. Eur J Immunol 1995;25:405-410
6. Qimron U, Madar N, Mittrucker HW, Zilka A, Yosef I, Bloushtain N, Kaufmann SH, Rosenshine I, Apte RN, Porgador A. Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules: Deltayej Salmonella mutants induce superior CD8+ T-cell responses. Cell Microbiol 2004;6:1057-1070 (Pubitemid 39386683)
7. Hummel S, Apte RN, Qimron U, Vitacolonna M, Porgador A, Zoller M. Tumor vaccination by Salmonella typhimurium after transformation with a eukaryotic expression vector in mice: impact of a Salmonella typhimurium gene interfering with MHC class I presentation. J Immunother 2005;28:467-479 (Pubitemid 41232568)
8. Xiang R, Mizutani N, Luo Y, Chiodoni C, Zhou H, Mizutani M, Ba Y, Becker JC, Reisfeld RA. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res 2005;65:553-561
9. Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998;281: 565-568 (Pubitemid 28357372)
10. Galan JE, Wolf-Watz H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 2006;444:567-573 (Pubitemid 44864429)
11. Marlovits TC, Kubori T, Sukhan A, Thomas DR, Galan JE, Unger VM. Structural insights into the assembly of the type III secretion needle complex. Science 2004;306:1040-1042 (Pubitemid 39482908)
12. Shams H, Poblete F, Russmann H, Galan JE, Donis RO. Induction of specific CD8+ memory T cells and longlasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. Vaccine 2001;20:577-585 (Pubitemid 32973803)
13. Evans DT, Chen LM, Gillis J, Lin KC, Harty B, Mazzara GP, Donis RO, Mansfield KG, Lifson JD, Desrosiers RC, Galan JE, Johnson RP. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J Virol 2003;77:2400-2409 (Pubitemid 36222763)
14. Nishikawa H, Sato E, Briones G, Chen LM, Matsuo M, Nagata Y, Ritter G, Jager E, Nomura H, Kondo S, Tawara I, Kato T, et al. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J Clin Invest 2006;116:1946-1954
15. Hensel M, Shea JE, Gleeson C, Jones MD, Dalton E, Holden DW. Simultaneous identification of bacterial virulence genes by negative selection. Science 1995;269: 400-403
16. Hensel M. Salmonella pathogenicity island 2. Mol Microbiol 2000;36:1015-1023
17. Abrahams GL, Hensel M. Manipulating cellular transport and immune responses: dynamic interactions between intracellular Salmonella enterica and its host cells. Cell Microbiol 2006;8:728-737
18. Husseiny MI, Wartha F, Hensel M. Recombinant vaccines based on translocated effector proteins of Salmonella pathogenicity island 2. Vaccine 2007;25: 185-193 (Pubitemid 44873037)
19. Swann JB, Coquet JM, Smyth MJ, Godfrey DI. CD1-restricted T cells and tumor immunity. Curr Top Microbiol Immunol 2007;314:293-323.
20. Cerundolo V, Silk JD, Masri SH, Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 2009;9:28-38.
21. Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 2007;5:405-417 (Pubitemid 46780078)
22. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005;434:520-525 (Pubitemid 40477061)
23. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, III, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005;434:525-529 (Pubitemid 40477062)
24. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia- Navarro R, Benhnia MR, Zajonc DM, Ben Menachem G, Ainge GD, Painter GF, Khurana A, Hoebe K, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006;7:978-986 (Pubitemid 44263912)
25. Berntman E, Rolf J, Johansson C, Anderson P, Cardell SL. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol 2005;35:2100-2109 (Pubitemid 41015049)
26. Nagarajan NA, Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 2007;178:2706-2713 (Pubitemid 46335652)
27. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1drestricted natural killer T cell activation during microbial infection. Nat Immunol 2003;4:1230-1237 (Pubitemid 37540692)
28. Zhou D, Mattner J, Cantu C, III, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004;306: 1786-1789 (Pubitemid 39601398)
29. Hermans IF, Silk JD, Gileadi U, Masri SH, Shepherd D, Farrand KJ, Salio M, Cerundolo V. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J Immunol 2007;178:2721-2729 (Pubitemid 46333148)
30. Song L, Ara T, Wu HW, Woo CW, Reynolds CP, Seeger RC, DeClerck YA, Thiele CJ, Sposto R, Metelitsa LS. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. J Clin Invest 2007;117: 2702-2712 (Pubitemid 47494370)
31. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981;291:238-239
32. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000;97:6640-6645
33. Deiwick J, Nikolaus T, Erdogan S, Hensel M. Environmental regulation of Salmonella pathogenicity island 2 gene expression. Mol Microbiol 1999;31:1759-1773 (Pubitemid 29151275)
34. Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 2001;167: 3114-3122 (Pubitemid 32852549)
35. Long X, Deng S, Mattner J, Zang Z, Zhou D, McNary N, Goff RD, Teyton L, Bendelac A, Savage PB. Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids. Nat Chem Biol 2007;3:559-564 (Pubitemid 47294396)
36. MacDonald TJ, Taga T, Shimada H, Tabrizi P, Zlokovic BV, Cheresh DA, Laug WE. Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist. Neurosurgery 2001;48:151-157
37. Burgos JS, Rosol M, Moats RA, Khankaldyyan V, Kohn DB, Nelson MD, Jr, Laug WE. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. Biotechniques 2003;34:1184-1188 (Pubitemid 36687600)
38. Metelitsa LS, Gillies SD, Super M, Shimada H, Reynolds CP, Seeger RC. Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis. Blood 2002;99:4166-4173
39. Metelitsa LS. Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cells. Clin Immunol 2004; 110:267-276 (Pubitemid 38402006)
40. Parekh VV, Wilson MT, Olivares-Villagomez D, Singh AK, Wu L, Wang CR, Joyce S, Van Kaer L. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 2005;115: 2572-2583 (Pubitemid 41266220)
41. Mobley JL, Rigby SM, Dailey MO. Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolytic T cells responding to minor histocompatibility antigens. J Immunol 1994;153:5443-5452
42. Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 2009;457:196-199
43. Husseiny MI, Hensel M. Construction of highly attenuated Salmonella enterica serovar Typhimurium live vectors for delivering heterologous antigens by chromosomal integration. Microbiol Res 2008;163:605-615
44. Husseiny MI, Hensel M. Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains. Infect Immun 2005;73:1598-1605 (Pubitemid 40470747)
45. Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 2002;99: 1259-1266 (Pubitemid 34547079)
46. Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos AK, Quest AF, Kiessling R. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma. Cancer Immunol Immunother 2009;59:81-92.
47. Ciesielski MJ, Kozbor D, Castanaro CA, Barone TA, Fenstermaker RA. Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma. Cancer Immunol Immunother 2008;57: 1827-1835
48. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 2002; 20:1063-1068 (Pubitemid 34141851)
49. Grunda JM, Nabors LB, Palmer CA, Chhieng DC, Steg A, Mikkelsen T, Diasio RB, Zhang K, Allison D, Grizzle WE, Wang W, Gillespie GY, et al. Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM). J Neurooncol 2006;80:261-274 (Pubitemid 44782903)
50. Uematsu M, Ohsawa I, Aokage T, Nishimaki K, Matsumoto K, Takahashi H, Asoh S, Teramoto A, Ohta S. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol 2005;72:231-238 (Pubitemid 40867405)
51. Shirai K, Suzuki Y, Oka K, Noda SE, Katoh H, Suzuki Y, Itoh J, Itoh H, Ishiuchi S, Sakurai H, Hasegawa M, Nakano T. Nuclear survivin expression predicts poorer prognosis in glioblastoma. J Neurooncol 2009;91:353-358
52. Jost SC, Wanebo JE, Song SK, Chicoine MR, Rich KM, Woolsey TA, Lewis JS, Mach RH, Xu J, Garbow JR. In vivo imaging in a murine model of glioblastoma. Neurosurgery 2007;60: 360-370
53. Sizemore DR, Branstrom AA, Sadoff JC. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 1995;270:299-302.
54. Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull World Health Organ 1994;72: 957-971
55. Gentschev I, Spreng S, Sieber H, Ures J, Mollet F, Collioud A, Pearman J, Griot- Wenk ME, Fensterle J, Rapp UR, Goebel W, Rothen SA, et al. Vivotif - a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens. Chemotherapy 2007;53:177-180
56. Thamm DH, Kurzman ID, King I, Li Z, Sznol M, Dubielzig RR, Vail DM, MacEwen EG. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation. Clin Cancer Res 2005;11:4827-4834 (Pubitemid 41557202)
57. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer LJ, Morton KE, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 2002;20:142-152 (Pubitemid 34032605)
58. Xiang R, Luo Y, Niethammer AG, Reisfeld RA. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis. Immunol Rev 2008;222:117-128 (Pubitemid 351430375)
59. Guillonneau C, Mintern JD, Hubert FX, Hurt AC, Besra GS, Porcelli S, Barr IG, Doherty PC, Godfrey DI, Turner SJ. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci USA 2009;106: 3330-3335
60. Charalambous A, Oks M, Nchinda G, Yamazaki S, Steinman RM. Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin. J Immunol 2006;177:8410-8421 (Pubitemid 44893803)
61. Yu P, Spiotto MT, Lee Y, Schreiber H, Fu YX. Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med 2003;197:985-995 (Pubitemid 36523196)
62. Husseiny MI, Hensel M. Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines. Vaccine 2005;23:2580-2590 (Pubitemid 40380802)
63. Terabe M, Swann J, Ambrosino E, Sinha P, Takaku S, Hayakawa Y, Godfrey DI, Ostrand-Rosenberg S, Smyth MJ, Berzofsky JA. A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 2005;202: 1627-1633 (Pubitemid 41815868)
64. Masson F, Calzascia T, Di Berardino-Besson W, de TN, Dietrich PY, Walker PR. Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells. J Immunol 2007; 179:845-853
65. Shea JE, Hensel M, Gleeson C, Holden DW. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci USA 1996;93:2593-2597 (Pubitemid 26104392)
66. Hensel M, Shea JE, Waterman SR, Mundy R, Nikolaus T, Banks G, Vazquez-Torres A, Gleeson C, Fang FC, Holden DW. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol 1998;30:163-174 (Pubitemid 28446628)